Condition
Stereotactic Body Radiation Therapy (SBRT) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Stereotactic Body Radiation Therapy (SBRT) clinical trials that are recruiting, at sites in 4 countries (most in Poland (2), China (2), United States (1)). By phase: Phase 2/3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Stereotactic Body Radiation Therapy (SBRT) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Stereotactic body radiation therapy for spinal metastases with epidural compression | — | Tianjin | Recruiting | Sep 9, 2026 |
| Prostate-first versus combined prostate and pelvic lymph node radiation dose escalation in PSMA PET–staged node-positive prostate cancer | Phase 2/3 | Zamość, Lublin Voivodeship | Recruiting | Feb 23, 2026 |
| Whole-gland prostate dose boost versus SBRT alone for PSMA-staged localized and locally advanced prostate cancer | Phase 2/3 | Zamość, Lublin Voivodeship | Recruiting | Feb 23, 2026 |
| Stereotactic body radiotherapy (SABR) for limited metastases | — | Seoul | Recruiting | Aug 13, 2025 |
| Practical geriatric assessment for older adults with early-stage non-small cell lung cancer receiving SBRT | — | Boston, Massachusetts | Recruiting | May 23, 2025 |
| Narlumosbart plus targeted bone radiation with chemo‑immunotherapy for advanced non‑small cell lung cancer that has spread to bone | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Dec 17, 2024 |
All recruiting trials (6)
-
Stereotactic body radiation therapy for spinal metastases with epidural compression
This study tests whether SBRT can safely help adults with spinal metastases that compress the spinal cord see if the treatment works in reducing issues from their cancer.
-
Prostate-first versus combined prostate and pelvic lymph node radiation dose escalation in PSMA PET–staged node-positive prostate cancer
This trial tests whether giving a stronger radiation boost to just the prostate first or to both the prostate and pelvic lymph nodes helps men whose prostate cancer has spread to nearby pelvic lymph nodes seen on PSMA PET.
-
Whole-gland prostate dose boost versus SBRT alone for PSMA-staged localized and locally advanced prostate cancer
We will test whether adding a whole-gland radiation boost (with brachytherapy or a stereotactic boost) improves cancer control compared with SBRT alone in men whose prostate cancer is confined to the prostate on PSMA PET.
-
Stereotactic body radiotherapy (SABR) for limited metastases
This program tries stereotactic body radiotherapy (SABR) in people with up to five oligometastatic or oligoprogressive cancer lesions to see if it controls disease better, affects symptoms and side effects, and changes ctDNA in the blood.
-
Practical geriatric assessment for older adults with early-stage non-small cell lung cancer receiving SBRT
This project will test whether a brief Practical Geriatric Assessment (PGA) can be used with adults 65+ who have stage I–II non-small cell lung cancer and are receiving stereotactic body radiation therapy to identify care needs and guide supportive referrals.
-
Narlumosbart plus targeted bone radiation with chemo‑immunotherapy for advanced non‑small cell lung cancer that has spread to bone
We will test whether adding narlumosbart (a RANKL‑targeting antibody) and targeted bone radiation to standard first‑line chemo‑immunotherapy helps people with advanced non‑small cell lung cancer that has spread to bone.
Related topics
Quick answers
How many Stereotactic Body Radiation Therapy (SBRT) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Poland (2 trials), China (2 trials), United States (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.